Cargando…

非小细胞肺癌免疫耐药机制及应对策略的研究进展

Immunotherapy has significantly improved clinical outcomes of non-small cell lung cancer (NSCLC), however, along with the popularization of immunotherapy, immune resistance has become an unavoidable problem. Immunotherapy can induce extensive cellular and molecular alterations in the tumor microenvi...

Descripción completa

Detalles Bibliográficos
Autores principales: JING, Yawan, ZENG, Hao, CHENG, Ruixin, TIAN, Panwen, LI, Yalun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial board of Chinese Journal of Lung Cancer 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987066/
https://www.ncbi.nlm.nih.gov/pubmed/36792083
http://dx.doi.org/10.3779/j.issn.1009-3419.2023.102.03